Safety and Efficacy of Fluvastatin in Heart Transplant Recipients.

Trial Profile

Safety and Efficacy of Fluvastatin in Heart Transplant Recipients.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Dec 2011

At a glance

  • Drugs Fluvastatin (Primary)
  • Indications Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 May 2010 Results presented at the 30th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
    • 05 May 2009 Planned end date (Nov 2008) added as reported by ClinicalTrials.gov.
    • 05 May 2009 Actual patient number (56) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top